Biocon, a leading biotechnology company, witnessed a rise in share price on Thursday after it reported a sharp rise of 78.76% in consolidated net profit for the quarter ended Mar. 31, 2015 to Rs 2.02 billion from Rs 1.13 billion in the same quarter previous year.

In Q4, Syngene has posted its strongest quarterly performance to date recording sales of Rs 2.38 billion and delivering 27% growth YoY. 
 
Net sales for the quarter rose 14.61% to Rs 8.55 billion, compared with Rs 7.46 billion for the prior year period.

Shares of the company are trading at Rs 455, up Rs 12.05, or 2.72% at the Bombay Stock Exchange (BSE) on Thursday at 9:54 a.m.

The scrip has touched an intra-day high of Rs 455.55 and low of Rs 449.40. The total volume of shares traded at the BSE is 54,375.